Article
p53 as the Focus of Gene Therapy: Past, Present and Future.
Current drug targets - 1 Jan 2018
Valente Joana F A, Queiroz João A, Sousa Fani
Abstract excerpt
BACKGROUND: Several gene deviations can be responsible for triggering oncogenic processes. However, mutations in tumour suppressor genes are usually more associated to malignant diseases, with p53 being one of the most affected and studied element. p53 is implicated in a number of known cellular functions, including DNA damage repair, cell cycle arrest in G1/S and G2/M and apoptosis, being an interesting target...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.